Product Information
OLANZAPINE 2.5 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.0811 per EA under NDC 72241005122. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on Feb 24, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241005122
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA210022FDA Approved
2/24/2023
TE Code
AB
On Market Since
2/27/2023
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 2.5 MG TABLET has been published 86 times since Feb 12, 2025, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0811 per EA |
|---|---|
| All-time high | $0.0849 (Mar 12, 2025) |
| All-time low | $0.0741 (May 21, 2025) |
| 52-week high | $0.0815 |
| 52-week low | $0.0776 |
| Median price | $0.0790 |
| Average price | $0.0791 |
| Largest weekly change | +7.3% (Feb 19, 2025) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 2.5 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.0811 per EA (NDC 72241005122), effective Sep 30, 2026.
How has the price of OLANZAPINE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 2.5 MG TABLET has risen 2.5%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 2.5 MG TABLET?
Since Feb 12, 2025, the NADAC for OLANZAPINE 2.5 MG TABLET has ranged from a low of $0.0741 (May 21, 2025) to a high of $0.0849 (Mar 12, 2025), with a median of $0.0790 per EA.
Are there cheaper alternatives to OLANZAPINE 2.5 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 2.5 MG TABLET, is $0.0769 per EA — about 5% below OLANZAPINE 2.5 MG TABLET.
Who manufactures OLANZAPINE 2.5 MG TABLET?
OLANZAPINE 2.5 MG TABLET (NDC 72241005122) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.